TriSalus Life Sciences Exceeds 2025 Revenue Guidance, Projects Strong 2026 Growth
TLSI sits 70% above its 52-week low of $3.42.
Summary
TriSalus Life Sciences announced preliminary unaudited financial results, reporting strong revenue growth for Q4 and full-year 2025 that exceeded prior guidance, and issued positive revenue guidance for 2026.
Key Events · Earnings and Guidance · TLSI
-
Exceeded 2025 Revenue Guidance
Reported preliminary full-year 2025 revenue of approximately $45.2 million, representing 53% year-over-year growth, surpassing the company's 50% annual growth guidance.
-
Strong Q4 2025 Revenue Growth
Announced preliminary fourth quarter 2025 revenue of approximately $13.2 million, a 60% increase year-over-year and 14% sequential quarterly growth.
-
Positive 2026 Revenue Guidance
Set initial 2026 revenue guidance in the range of approximately $60 million to $62 million, indicating continued significant growth.
-
Cash Position Update
Estimated cash and cash equivalents of approximately $20.4 million as of December 31, 2025, reflecting a $2.3 million reduction during Q4 2025.
Analysis · TLSI · Industrial Applications And Services
The preliminary financial results indicate robust commercial performance, with full-year 2025 revenue surpassing the company's 50% growth target. The initial 2026 revenue guidance projects continued significant growth, reinforcing confidence in the company's strategic initiatives and product adoption. While cash and cash equivalents saw a modest reduction in Q4, the focus on operational efficiency alongside strong revenue growth suggests a manageable financial trajectory. Investors should monitor the final audited results and the company's progress towards its 2026 revenue targets.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1661 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TLSI was trading at $5.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $306.8M. The 52-week trading range was $3.42 to $7.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.